[Nimesil effectiveness in rheumatoid arthritis].

@article{Balabanova2002NimesilEI,
  title={[Nimesil effectiveness in rheumatoid arthritis].},
  author={R. M. Balabanova and B S Belov and N V Chichasova and Iu A Oliunin and V V Badokin and A O Pchelintseva and T P Fedina and D A Gukasian and N E Lopatina and N Ia Korshunov and Elena Baranov{\'a} and Elena Ilivanova and S E Trifonova and G K Matsievskaia},
  journal={Klinicheskaia meditsina},
  year={2002},
  volume={80 6},
  pages={49-52}
}
Clinical efficiency and safety of nimesil were studied in the multicenter open clinical trial of 52 patients with verified rheumatoid arthritis. Nimesil was given for 12 weeks in a daily dose 200-400 mg in addition to basic therapy. Clinical and laboratory parameters were assessed after 4 and 8 weeks of the treatment and after its end. The treatment… CONTINUE READING